<DOC>
	<DOC>NCT01302158</DOC>
	<brief_summary>A study to investigate the effect of ASP1941 on the pharmacokinetics and safety of glimepiride (Part A) and to investigate the effect of glimepiride on the pharmacokinetics, safety and pharmacodynamics of ASP1941 (Part B).</brief_summary>
	<brief_title>Drug-drug Interaction Study With ASP1941 and Glimepiride</brief_title>
	<detailed_description>Study includes two parts. Part A is to investigate the effect of multiple oral doses of ASP1941 on the pharmacokinetics of glimepiride, and Part B is to investigate the effect of multiple oral doses of glimepiride on the pharmacokinetics of ASP1941.</detailed_description>
	<mesh_term>Glimepiride</mesh_term>
	<criteria>BMI between 18.5 and 30 kg/m2, inclusive Any of the liver function tests above the upper limit of normal Pulse &lt;40 or &gt;90 bpm; Systolic Blood Pressure &gt;140 mmHg; Diastolic Blood Pressure &gt; 90 mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Drug-Drug interaction</keyword>
	<keyword>ASP1941</keyword>
	<keyword>Glimepiride</keyword>
	<keyword>Healthy subjects</keyword>
</DOC>